Nov 30, 2020 · The transatlantic clinical trial found that Zio by iRhythm, an ambulatory cardiac monitoring solution, led to a tenfold increase in the detection of atrial fibrillation (AF) versus patients receiving standard clinical care.

Afib events were identified in 18 additional individuals, and the documented pattern of Afib (persistent or paroxysmal) changed in 21 patients after Zio Patch monitoring. As a result of the findings from the Zio Patch, 28.4% of patients had a change in their clinical management.

Dec 5, 2024 · I have a 16 year history of afib and for the majority of that time it was controlled through flecainide and metoprolol. An ablation in 2018 controlled it for about 8 months. In March of this year I got COVID and my paroxysmal afib shifted to constant afib.

Apr 4, 2022 · New clinical research presented at ACC.22 shows that the Zio service is a viable solution for the early detection of silent atrial fibrillation. Additional data shows that Zio AT can positively impact hospital resources – saving one healthcare system …

Feb 17, 2025 · Screening people in primary care with a wearable heart monitor developed by iRhythm was able to increase diagnoses of atrial fibrillation (AFib) by 52%, although it did not result in a reduction...

We compared the Zio ® Patch, a single-use, noninvasive waterproof long-term continuous monitoring patch, with a 24-hour Holter monitor in 74 consecutive patients with paroxysmal AF referred for Holter monitoring for detection of arrhythmias. The Zio ® Patch was well tolerated, with a mean monitoring period of 10.8 ± 2.8 days (range 4–14 days).

Wearables maker iRhythm Technologies on Monday released data suggesting its Zio patch increased the rate of atrial fibrillation (AFib) detection and reduced cardiac events, in results presented at the American Heart Association's annual scientific meeting.

Jul 17, 2018 · The Zio patch is a 2-by-5-inch adhesive patch, much like a bandage, and is worn on the upper left side of the chest. It’s water resistant and can be kept on even while a person exercises or takes a shower.

Mar 11, 2013 · iRhythm Technologies has announced that clinical study findings showing that use of the Zio Patch resulted in a change in treatment strategy for nearly one-third of patients with paroxysmal atrial fibrillation.

Apr 4, 2022 · iRhythm Technologies (Nasdaq:IRTC) announced results of multiple studies supporting the use of its Zio technology in detecting AFib. San Francisco-based iRhythm presented the results of three...